Structures by: Ahmad M.
Total: 146
(3-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2010) 66, 4 o885
a=4.7151(3)Å b=12.2879(8)Å c=12.5809(6)Å
α=81.375(3)° β=84.463(3)° γ=85.608(3)°
3-Benzoyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C15H11NO4S
Acta Crystallographica Section E (2010) 66, 4 o862
a=13.8675(4)Å b=7.6289(2)Å c=25.7553(9)Å
α=90.00° β=102.4519(12)° γ=90.00°
Isopropyl 2-(3,4-dimethyl-5,5-dioxo-4<i>H</i>-pyrazolo[4,3-<i>c</i>][1,2]benzothiazin- 2-yl)acetate
C16H19N3O4S
Acta Crystallographica Section E (2010) 66, 10 o2630
a=7.6370(2)Å b=8.5412(2)Å c=13.3096(4)Å
α=98.4584(18)° β=97.4870(13)° γ=95.9599(17)°
4-Hydroxy-2-[(4-iodobenzoyl)methyl]-3-(3-methoxybenzoyl)-2<i>H</i>- 1,2-benzothiazine 1,1-dioxide
C24H18INO6S
Acta Crystallographica Section E (2010) 66, 9 o2327
a=9.7392(2)Å b=11.5288(3)Å c=20.4634(4)Å
α=90.00° β=100.5288(11)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-1-(2-Hydroxyphenyl)ethylidene]pyrazine-2-carbohydrazide
C13H12N4O2
Acta Crystallographica Section E (2013) 69, 9 o1419
a=7.1767(7)Å b=10.1743(10)Å c=17.1150(17)Å
α=86.172(3)° β=85.275(2)° γ=80.963(4)°
<i>N</i>'-[(<i>E</i>)-3-Bromobenzylidene]pyrazine-2-carbohydrazide
C12H9BrN4O
Acta Crystallographica Section E (2013) 69, 11 o1635
a=14.4115(8)Å b=6.2128(3)Å c=27.5992(15)Å
α=90° β=104.379(2)° γ=90°
3-[4-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)phenyl]-2-hydroxy-1-mesitylprop-2-en-1-one hexane hemisolvate
C29H27N3O4S,0.5(C6H14)
Acta Crystallographica Section E (2012) 68, 2 o460-o461
a=7.1772(2)Å b=23.2178(5)Å c=16.7740(4)Å
α=90.00° β=99.5260(10)° γ=90.00°
2-(3-Benzoyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1λ^6^,2-benzothiazin-2-yl)- 1-phenylethanone
C23H17NO5S
Acta Crystallographica Section E (2012) 68, 1 o92
a=7.5458(2)Å b=10.9169(4)Å c=12.0924(4)Å
α=101.920(2)° β=101.423(2)° γ=90.484(2)°
<i>N</i>^1^-[(1<i>H</i>-Imidazol-2-yl)methylidene]-<i>N</i>^4^-phenylbenzene-1,4-diamine
C16H14N4
Acta Crystallographica Section E (2014) 70, 7 o806
a=15.663(5)Å b=5.063(3)Å c=16.800(5)Å
α=90.00° β=93.124(5)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-1-(4-methoxyphenyl)ethanone
C20H19N3O4S
Acta Crystallographica Section E (2012) 68, 2 o458-o459
a=13.862(5)Å b=8.079(2)Å c=17.748(7)Å
α=90.00° β=108.372(18)° γ=90.00°
3,4-Dimethyl-2-(2-oxo-2-phenylethyl)-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazine-5,5-dione
C19H17N3O3S
Acta Crystallographica Section E (2012) 68, 2 o502
a=24.380(6)Å b=11.141(4)Å c=14.996(5)Å
α=90.00° β=120.76(2)° γ=90.00°
2-[2-(3-Chlorophenyl)-2-oxoethyl]-4-hydroxy-3-(3-methoxybenzoyl)- 2<i>H</i>-1λ^6^,2-benzothiazine-1,1-dione
C24H18ClNO6S
Acta Crystallographica Section E (2012) 68, 4 o980-o981
a=10.2562(3)Å b=10.9602(3)Å c=11.3861(4)Å
α=116.5460(15)° β=105.3216(13)° γ=97.2383(14)°
3-[Hydroxy(3-methoxyphenyl)methylidene]-2-(2-oxo-2-phenylethyl)- 3,4-dihydro-2<i>H</i>-1λ^6^,2-benzothiazine-1,1,4-trione
C24H19NO6S
Acta Crystallographica Section E (2012) 68, 4 o978-o979
a=17.9615(5)Å b=11.2633(3)Å c=19.5904(6)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Chlorophenyl)-2-[4-hydroxy-3-(3-methoxybenzoyl)-1,1-dioxo-2<i>H</i>- 1λ^6^,2-benzothiazin-2-yl]ethanone
C24H18ClNO6S
Acta Crystallographica Section E (2012) 68, 4 o1058-o1059
a=7.2656(2)Å b=11.4237(4)Å c=12.8997(5)Å
α=97.147(2)° β=96.934(2)° γ=91.166(2)°
[2-(2,5-Dichlorobenzyl)-4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin- 3-yl](phenyl)methanone
C22H15Cl2NO4S
Acta Crystallographica Section E (2012) 68, 5 o1359
a=12.8172(5)Å b=9.9215(4)Å c=16.7155(5)Å
α=90.000(2)° β=110.511(2)° γ=90.000(2)°
(2-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2012) 68, 5 o1326
a=12.1078(6)Å b=8.4057(5)Å c=14.7022(9)Å
α=90.00° β=105.541(3)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)acetic acid
C13H13N3O4S
Acta Crystallographica Section E (2012) 68, 6 o1970-o1971
a=10.495(4)Å b=8.415(2)Å c=15.136(6)Å
α=90.00° β=91.034(19)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>-(2-fluorobenzyl)acetamide
C20H19FN4O3S
Acta Crystallographica Section E (2012) 68, 8 o2470-o2471
a=27.4331(15)Å b=7.4519(5)Å c=9.2598(6)Å
α=90.00° β=90.00° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>-(3-methoxybenzyl)acetamide
C21H22N4O4S
Acta Crystallographica Section E (2012) 68, 11 o3064-o3065
a=8.65410(10)Å b=25.8809(3)Å c=18.3892(2)Å
α=90.00° β=92.2080(10)° γ=90.00°
Ethyl 2-(3,4-dimethyl-5,5-dioxo-1<i>H</i>,4<i>H</i>- benzo[<i>e</i>]pyrazolo[4,3-<i>c</i>][1,2]thiazin-1-yl)acetate
C15H17N3O4S
Acta Crystallographica Section E (2012) 68, 10 o3010
a=8.3027(2)Å b=8.5915(3)Å c=22.3476(7)Å
α=90.00° β=90.674(2)° γ=90.00°
4-Methyl-3-phenyl-2,4-dihydropyrazolo[4,3-<i>c</i>][1,2]benzothiazine 5,5-dioxide
C16H13N3O2S
Acta Crystallographica Section E (2012) 68, 9 o2615-o2616
a=12.1028(5)Å b=16.3934(7)Å c=7.0962(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-Bromobenzylidene]pyrazine-2-carbohydrazide
C12H9BrN4O
Acta Crystallographica Section E (2013) 69, 7 o1141
a=5.8947(9)Å b=7.6941(12)Å c=14.029(2)Å
α=83.273(7)° β=80.086(7)° γ=72.440(6)°
C5H4ClCuN
C5H4ClCuN
ACS omega (2019) 4, 4 7738-7749
a=3.7495(8)Å b=12.724(2)Å c=11.3220(18)Å
α=90° β=93.668(5)° γ=90°
C48H46Co4N4O21
C48H46Co4N4O21
Crystal Growth & Design (2012) 12, 3 1571
a=10.659(3)Å b=14.708(5)Å c=16.638(5)Å
α=83.681(5)° β=71.443(2)° γ=87.964(5)°
C22H21Co2NO11
C22H21Co2NO11
Crystal Growth & Design (2012) 12, 3 1571
a=8.005(2)Å b=10.744(5)Å c=14.402(5)Å
α=97.640(3)° β=91.050(5)° γ=109.285(2)°
C21H16CoN2O8
C21H16CoN2O8
Crystal Growth & Design (2012) 12, 9 4624
a=7.341(4)Å b=9.823(6)Å c=13.683(5)Å
α=90.119(3)° β=90.245(6)° γ=104.146(5)°
C64H90Co3N8O30
C64H90Co3N8O30
Crystal Growth & Design (2012) 12, 9 4624
a=9.730(7)Å b=10.190(5)Å c=19.529(6)Å
α=78.011(5)° β=80.400(8)° γ=87.705(7)°
C42H54Co3N2O28
C42H54Co3N2O28
Crystal Growth & Design (2012) 12, 9 4624
a=8.280(6)Å b=10.184(5)Å c=15.679(4)Å
α=81.102(3)° β=85.719(5)° γ=74.985(6)°
C41H39Mn3N3O17
C41H39Mn3N3O17
Crystal Growth & Design (2012) 12, 9 4624
a=19.194(6)Å b=10.022(4)Å c=21.904(5)Å
α=90.000° β=90.194(5)° γ=90.000°
C44H32O10Zn3
C44H32O10Zn3
Crystal Growth & Design (2013) 13, 6 2618
a=29.411(4)Å b=24.104(7)Å c=5.966(5)Å
α=90.000° β=100.043(5)° γ=90.000°
C30H26N2O4Zn
C30H26N2O4Zn
Crystal Growth & Design (2013) 13, 6 2618
a=9.728(4)Å b=11.672(5)Å c=14.554(5)Å
α=93.466(5)° β=96.367(5)° γ=93.175(5)°
C24H22NO4Zn
C24H22NO4Zn
Crystal Growth & Design (2013) 13, 6 2618
a=13.887(5)Å b=9.302(4)Å c=32.649(5)Å
α=90.000° β=90.000° γ=90.000°
C66H48O13Pb3
C66H48O13Pb3
Crystal Growth & Design (2013) 13, 6 2618
a=35.402(5)Å b=15.813(6)Å c=11.424(5)Å
α=90.000° β=90.361(5)° γ=90.000°
C63H39ClCo2N12O6
C63H39ClCo2N12O6
Crystal Growth & Design (2012) 12, 6 2999
a=17.031(5)Å b=17.031(5)Å c=13.922(4)Å
α=90.000° β=90.000° γ=120.000°
C126H78Mn3N24O12
C126H78Mn3N24O12
Crystal Growth & Design (2012) 12, 6 2999
a=13.611(5)Å b=14.580(6)Å c=15.041(4)Å
α=71.922(3)° β=65.006(4)° γ=80.586(6)°
C45H49Cl2N15O11Zn
C45H49Cl2N15O11Zn
Crystal Growth & Design (2012) 12, 10 5025
a=13.163(2)Å b=21.296(5)Å c=18.947(3)Å
α=90.000(5)° β=106.167(5)° γ=90.000(7)°
C48H56Cl2CuN16O12
C48H56Cl2CuN16O12
Crystal Growth & Design (2012) 12, 10 5025
a=9.281(7)Å b=10.472(5)Å c=14.731(3)Å
α=77.108(5)° β=75.560(2)° γ=82.591(5)°
C20H16N6O4Zn
C20H16N6O4Zn
Crystal Growth & Design (2012) 12, 10 5025
a=7.908(5)Å b=11.995(4)Å c=20.795(5)Å
α=90.000(6)° β=96.074(5)° γ=90.000(2)°
C18H14ClCuN6
C18H14ClCuN6
Crystal Growth & Design (2012) 12, 10 5025
a=15.788(2)Å b=10.040(5)Å c=11.544(4)Å
α=90.000(5)° β=109.688(6)° γ=90.000(5)°
C36H28Cl2N12O8Zn
C36H28Cl2N12O8Zn
Crystal Growth & Design (2012) 12, 10 5025
a=13.419(5)Å b=20.811(2)Å c=19.156(7)Å
α=90.000(2)° β=108.284(5)° γ=90.000(5)°
C18H16ClCuN6O
C18H16ClCuN6O
Crystal Growth & Design (2012) 12, 10 5025
a=8.253(3)Å b=8.374(5)Å c=12.733(4)Å
α=85.951(5)° β=79.422(7)° γ=77.990(5)°
Methyl 7-oxo-2-phenyl-7H-[1,2,4]triazolo[5,1-b][1,3]thiazine-5-carboxylate
C13H9N3O3S
RSC Adv. (2015)
a=7.1783(10)Å b=14.804(2)Å c=12.0251(19)Å
α=90.00° β=97.835(6)° γ=90.00°
5-phenyl-7H-[1,2,4]triazolo[5,1-b][1,3]thiazin-7-one (49)
C11H7N3OS
RSC Adv. (2015)
a=6.9892(6)Å b=10.5036(10)Å c=13.4268(13)Å
α=90° β=104.277(4)° γ=90°
C56H52Cl4Co4N10O20
C56H52Cl4Co4N10O20
Dalton transactions (Cambridge, England : 2003) (2013) 42, 26 9513-9522
a=15.483(2)Å b=13.791(2)Å c=15.873(2)Å
α=90.00° β=99.667(2)° γ=90.00°
C27H21NO4Zn
C27H21NO4Zn
Crystal Growth & Design (2013) 13, 6 2618
a=10.547(5)Å b=19.841(5)Å c=14.599(5)Å
α=90.000° β=102.868(5)° γ=90.000°
C70H58O19Pb4
C70H58O19Pb4
Crystal Growth & Design (2013) 13, 6 2618
a=40.205(5)Å b=6.984(7)Å c=26.098(5)Å
α=90.000° β=118.408(5)° γ=90.000°